Compliance certificate for the quarter ended March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr Lalchandani Labs Ltd has submitted a routine compliance certificate for the quarter ended March 31, 2025, as required under SEBI's Regulation 74(5). The certificate was issued by the company's Registrar and Share Transfer Agent, Cameo Corporate Services Limited, on April 5, 2025. It confirms that all securities received from depository participants for dematerialization during the quarter were properly processed and confirmed to the depositories. The RTA also confirms that physical share certificates received for demat conversion were mutilated and cancelled, and the depositories' names were recorded as the registered owners in the company's register of members within the stipulated timeline. The filing was signed by Managing Director Arjan Lal Chandani and submitted to BSE (Scrip Code: 541299) on April 14, 2025.
This is a standard regulatory housekeeping filing with no material impact on the company's operations, financials, or shareholders. Investors should note it only as a routine confirmation that the company's share transfer processes are functioning in compliance with SEBI norms.